ID

17180

Description

Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00607932

Link

https://clinicaltrials.gov/show/NCT00607932

Keywords

  1. 8/30/16 8/30/16 -
Uploaded on

August 30, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00607932

Eligibility Prostate Cancer NCT00607932

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of prostate cancer with psa recurrence after prostatectomy
Description

Prostate cancer with psa recurrence after prostatectomy

Data type

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C2985506
UMLS CUI [2,2]
C0033573
psa recurrence is defined as two consecutively rising psa tests ≥ 8 weeks since the post-surgical nadir, with a minimal interval of 2 weeks between tests and at least 1 psa test > 0.4 ng/ml
Description

PSA recurrence

Data type

boolean

Alias
UMLS CUI [1]
C0201544
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
life expectancy ≥ 9 months
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
no predictors of poor adherence (e.g., erratic life-style, mental incompetence)
Description

Compliance behavior

Data type

boolean

Alias
UMLS CUI [1]
C1321605
prior concurrent therapy: see disease characteristics
Description

concurrent therapy

Data type

boolean

Alias
UMLS CUI [1]
C0009429
no other concurrent brassica vegetable consumption > 1 serving/day
Description

brassica vegetable consumption

Data type

boolean

Alias
UMLS CUI [1]
C0453113
no other concurrent indole-3-carbinol supplements
Description

Indole-3-carbinol supplements

Data type

boolean

Alias
UMLS CUI [1]
C0063491
no endocrine or radiation treatment within past 4 weeks
Description

no endocrine or radiation treatment

Data type

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C1522449
no other scheduled treatment during study intervention
Description

other treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205394
concurrent prescription medications during the trial allowed
Description

prescription medications

Data type

boolean

Alias
UMLS CUI [1]
C0304227
at least 2 weeks since prior and no concurrent vitamin or herbal supplement use
Description

vitamin or herbal supplement use

Data type

boolean

Alias
UMLS CUI [1]
C0681579
UMLS CUI [2]
C1504473
patients refusing to stop non-study supplements will be asked to maintain constant use
Description

patients refusing to stop non-study supplements will be asked to maintain constant use

Data type

boolean

Alias
UMLS CUI [1,1]
C0242295
UMLS CUI [1,2]
C0205360

Similar models

Eligibility Prostate Cancer NCT00607932

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate cancer with psa recurrence after prostatectomy
Item
diagnosis of prostate cancer with psa recurrence after prostatectomy
boolean
C0600139 (UMLS CUI [1])
C2985506 (UMLS CUI [2,1])
C0033573 (UMLS CUI [2,2])
PSA recurrence
Item
psa recurrence is defined as two consecutively rising psa tests ≥ 8 weeks since the post-surgical nadir, with a minimal interval of 2 weeks between tests and at least 1 psa test > 0.4 ng/ml
boolean
C0201544 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
life expectancy
Item
life expectancy ≥ 9 months
boolean
C0023671 (UMLS CUI [1])
Compliance behavior
Item
no predictors of poor adherence (e.g., erratic life-style, mental incompetence)
boolean
C1321605 (UMLS CUI [1])
concurrent therapy
Item
prior concurrent therapy: see disease characteristics
boolean
C0009429 (UMLS CUI [1])
brassica vegetable consumption
Item
no other concurrent brassica vegetable consumption > 1 serving/day
boolean
C0453113 (UMLS CUI [1])
Indole-3-carbinol supplements
Item
no other concurrent indole-3-carbinol supplements
boolean
C0063491 (UMLS CUI [1])
no endocrine or radiation treatment
Item
no endocrine or radiation treatment within past 4 weeks
boolean
C0279025 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
other treatment
Item
no other scheduled treatment during study intervention
boolean
C0087111 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
prescription medications
Item
concurrent prescription medications during the trial allowed
boolean
C0304227 (UMLS CUI [1])
vitamin or herbal supplement use
Item
at least 2 weeks since prior and no concurrent vitamin or herbal supplement use
boolean
C0681579 (UMLS CUI [1])
C1504473 (UMLS CUI [2])
patients refusing to stop non-study supplements will be asked to maintain constant use
Item
patients refusing to stop non-study supplements will be asked to maintain constant use
boolean
C0242295 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial